Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
What type of healthcare provider should I consult regarding BPC 157
The subcutaneous tissue adjacent to the injury provides an optimal depot from which BPC-157 diffuses to target structures
Where required, we incorporate evidence-based supplements to support healing pathways, antioxidant defence and connective tissue repair
The four large CDMOs (Bachem, AmbioPharm, CordenPharma, and PolyPeptide Group) are included for completeness
The progressive ramp through the cycle is intentional: it allows the body to respond to the compound gradually, lets the provider assess tolerance and response before increasing the dose, and avoids the unnecessary load of starting at maximum dosing when the tissue is still in early repair phases
